LYTIR

Company · PALI

Palisade Bio, Inc.

Name as listed on its exchange; filed with the SEC as PALISADE BIO, INC.

Nasdaq's symbol directory lists PALI on Nasdaq as “Palisade Bio, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 8 occasions ($279K); insiders sold on 2 occasions ($410K); 4 filings by holders of 5% or more.

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $279K in total; Insider sales: $410K in total.Jul: Insider purchases $250KJul: Insider sales $410KOct: Insider purchases $29KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $279KInsider sales below: $410K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Finley John David, CEO, CFO sold on 1 day latest Jul 7, 2026 sold $303K
  2. Robert Baltera Jr. bought on 6 days latest Jul 9, 2026 bought $250K
  3. Jones Mitchell Lawrence, Chief Medical Officer sold on 1 day latest Jul 7, 2026 sold $107K
  4. Donald Allen Williams bought on 2 days latest Oct 2, 2026 bought $29K
Every trade (10)
  1. BUYDonald Allen Williams bought Oct 2, 2026 10,000 shares filing $15K
  2. BUYDonald Allen Williams bought Oct 1, 2026 10,000 shares filing $14K
  3. BUYRobert Baltera Jr. bought Jul 9, 2026 25,000 shares filing $49K
  4. BUYRobert Baltera Jr. bought Jul 8, 2026 20,000 shares filing $40K
  5. SELLFinley John David, CEO, CFO sold Jul 7, 2026 146,798 shares filing $303K
  6. SELLJones Mitchell Lawrence, Chief Medical Officer sold Jul 7, 2026 51,880 shares filing $107K
  7. BUYRobert Baltera Jr. bought Jul 7, 2026 30,000 shares filing $61K
  8. BUYRobert Baltera Jr. bought Jul 6, 2026 20,000 shares filing $41K
  9. BUYRobert Baltera Jr. bought Jul 2, 2026 10,000 shares filing $20K
  10. BUYRobert Baltera Jr. bought Jul 1, 2026 20,000 shares filing $40K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Vanguard Capital Management filed Oct 30, 2026 Schedule 13G passive 8,995,805 shares filing 5.16%
  2. Commodore Capital LP filed Aug 14, 2026 Schedule 13G/A passive filing 0%
  3. Soleus Capital Master Fund, L.P. filed Aug 13, 2026 Schedule 13G/A passive filing 7.5%
  4. BlackRock, Inc. filed Jul 29, 2026 Schedule 13G passive 10,436,760 shares filing 6%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.